GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Short-Term Debt

BYSI (BeyondSpring) Short-Term Debt : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Short-Term Debt?

BeyondSpring's Short-Term Debt for the quarter that ended in Dec. 2024 was $0.00 Mil.


BeyondSpring Short-Term Debt Historical Data

The historical data trend for BeyondSpring's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Short-Term Debt Chart

BeyondSpring Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.57 - - -

BeyondSpring Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BeyondSpring Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


BeyondSpring Short-Term Debt Related Terms

Thank you for viewing the detailed overview of BeyondSpring's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


BeyondSpring Business Description

Traded in Other Exchanges
N/A
Address
100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.